Capricor Therapeutics | CAPR - Ebit

Aktienkurs
30.10
Täglich Wechseln
1.00 3.44%
Monatlich
7.85%
Jährlich
126.66%
Q1 Prognose
28.23




Ebit Veränderung Datum
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Bioline Rx USD -673K 2.99M 2025-09
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Geron USD -10.79M 3.1M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -22.81M 756K 2024-06
J&J USD 5.11B 2.3B 2025-12
Prothena USD -27.21M 12.55M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12